Cargando…

Robotic Intracorporeal Ileal Conduit Formation: Initial Experience from a Single UK Centre

Objectives. To describe our technique of robotic intracorporeal ileal conduit formation (RICIC) during robotic-assisted radical cystectomy (RARC). To report our initial results of this new procedure. Patients and Methods. Seven male and one female patients underwent RARC with RICIC over a six-month...

Descripción completa

Detalles Bibliográficos
Autores principales: Bishop, Conrad V., Vasdev, Nikhil, Boustead, Gregory, Adshead, James M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3773896/
https://www.ncbi.nlm.nih.gov/pubmed/24072995
http://dx.doi.org/10.1155/2013/642836
_version_ 1782284444418179072
author Bishop, Conrad V.
Vasdev, Nikhil
Boustead, Gregory
Adshead, James M.
author_facet Bishop, Conrad V.
Vasdev, Nikhil
Boustead, Gregory
Adshead, James M.
author_sort Bishop, Conrad V.
collection PubMed
description Objectives. To describe our technique of robotic intracorporeal ileal conduit formation (RICIC) during robotic-assisted radical cystectomy (RARC). To report our initial results of this new procedure. Patients and Methods. Seven male and one female patients underwent RARC with RICIC over a six-month period. Demographic, operative, and outcome data was collected prospectively. Median patient age was 75 years (range 62–78 years). Median followup was 9 months (range 7–14 months). Results. RARC with RICIC was performed successfully in all eight patients. The median total operating time was 360 minutes (range 310–440 minutes) with a median blood loss of 225 mL (range 50–1000 mL). The median length of stay was nine days (range 6–34 days). Four patients (50%) were discharged within seven days. Four patients (50%) experienced one or more complications. This included two Clavien I complications, two Clavien II complications, and two Clavien III complications. Two patients (25%) required transfusion of two units each. To date, there have been no complications associated with the ileal conduit. Conclusion. Whilst being technically challenging, this procedure is safe, feasible, and reproducible. Patients who avoid complication show potential for rapid recovery and early discharge.
format Online
Article
Text
id pubmed-3773896
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-37738962013-09-26 Robotic Intracorporeal Ileal Conduit Formation: Initial Experience from a Single UK Centre Bishop, Conrad V. Vasdev, Nikhil Boustead, Gregory Adshead, James M. Adv Urol Clinical Study Objectives. To describe our technique of robotic intracorporeal ileal conduit formation (RICIC) during robotic-assisted radical cystectomy (RARC). To report our initial results of this new procedure. Patients and Methods. Seven male and one female patients underwent RARC with RICIC over a six-month period. Demographic, operative, and outcome data was collected prospectively. Median patient age was 75 years (range 62–78 years). Median followup was 9 months (range 7–14 months). Results. RARC with RICIC was performed successfully in all eight patients. The median total operating time was 360 minutes (range 310–440 minutes) with a median blood loss of 225 mL (range 50–1000 mL). The median length of stay was nine days (range 6–34 days). Four patients (50%) were discharged within seven days. Four patients (50%) experienced one or more complications. This included two Clavien I complications, two Clavien II complications, and two Clavien III complications. Two patients (25%) required transfusion of two units each. To date, there have been no complications associated with the ileal conduit. Conclusion. Whilst being technically challenging, this procedure is safe, feasible, and reproducible. Patients who avoid complication show potential for rapid recovery and early discharge. Hindawi Publishing Corporation 2013 2013-09-01 /pmc/articles/PMC3773896/ /pubmed/24072995 http://dx.doi.org/10.1155/2013/642836 Text en Copyright © 2013 Conrad V. Bishop et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Bishop, Conrad V.
Vasdev, Nikhil
Boustead, Gregory
Adshead, James M.
Robotic Intracorporeal Ileal Conduit Formation: Initial Experience from a Single UK Centre
title Robotic Intracorporeal Ileal Conduit Formation: Initial Experience from a Single UK Centre
title_full Robotic Intracorporeal Ileal Conduit Formation: Initial Experience from a Single UK Centre
title_fullStr Robotic Intracorporeal Ileal Conduit Formation: Initial Experience from a Single UK Centre
title_full_unstemmed Robotic Intracorporeal Ileal Conduit Formation: Initial Experience from a Single UK Centre
title_short Robotic Intracorporeal Ileal Conduit Formation: Initial Experience from a Single UK Centre
title_sort robotic intracorporeal ileal conduit formation: initial experience from a single uk centre
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3773896/
https://www.ncbi.nlm.nih.gov/pubmed/24072995
http://dx.doi.org/10.1155/2013/642836
work_keys_str_mv AT bishopconradv roboticintracorporealilealconduitformationinitialexperiencefromasingleukcentre
AT vasdevnikhil roboticintracorporealilealconduitformationinitialexperiencefromasingleukcentre
AT bousteadgregory roboticintracorporealilealconduitformationinitialexperiencefromasingleukcentre
AT adsheadjamesm roboticintracorporealilealconduitformationinitialexperiencefromasingleukcentre